Riskpilot← Back to searchSign inGet full accessSPS Laboratories AB
ABBankruptOrg 5567676126Wholesale of other food · NACE 4638Est. 20080 employees
Revenue 2019
SEK 438K
+31% vs 2018
EBITDA margin
-82.2%
-129% vs 2018
Equity ratio
62.7%
Financial strength
Net profit 2019
SEK -362K
-128% vs 2018
| Revenue | SEK 438K | +31% |
| EBITDA | SEK -360K | -129% |
| Net profit | SEK -362K | -128% |
| Total assets | SEK 102K | -80% |
| Equity | SEK 64K | -73% |
| Employees | 0 | — |
Legal name
SPS Laboratories AB
Org number
5567676126
Legal form
Aktiebolag
NACE code
4638 · Wholesale of other food
Founded
15 oktober 2008
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Company purpose
Bolaget skall bedriva forskning, utveckling och försäljning av läkemedel och kosttillskott, läkarverksamhet samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Revenue | — | 327 | 744 | 335 | 438 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −178 | 125 | 179 | −157 | −360 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −178 | 125 | 179 | −157 | −360 |
| Net financials | — | — | −9 | −2 | −2 |
| Profit before tax | −178 | 124 | 169 | −159 | −362 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −178 | 124 | 169 | −159 | −362 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Total assets | 419 | 721 | 848 | 505 | 102 |
| Equity | 103 | 227 | 396 | 238 | 64 |
| Long-term debt | 294 | 294 | 294 | 122 | 0 |
| Short-term debt | 22 | 199 | 157 | 145 | 38 |
| Total debt | 316 | 493 | 451 | 267 | 38 |
EBITDA margin
-82.2%
This company
15.8%
Market median
-620% vs market
20152019
Equity ratio
62.7%
This company
38.2%
Market median
+64% vs market
20152019
Return on equity
-565.6%
This company
18.4%
Market median
-3174% vs market
20152019
Net profit margin
-82.6%
This company
8.1%
Market median
-1120% vs market
20152019
Asset turnover
4.29×
This company
1.12×
Market median
+283% vs market
20152019
Debt / equity
0.59×
This company
0.62×
Market median
+5% vs market
20152019
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
KA Authorized Recipient of Service | Authorized Recipient of Service | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SPS Laboratories AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karin Anita Joneryd | Authorized Recipient of Service | 0 companies |
| Frank Leo Eriksen | Board of Directors | 0 companies |
| Svein Erik Dørum | Deputy Board Member | 0 companies |